Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
5 hedge funds and large institutions have $3.28M invested in Biocept, Inc. in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GBA
Garrison Bradford & Associates
New York
|
+$1.36M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$678K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$678K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$226K |
Top Sellers
BIOC Hedge Fund Activity: Q1 2014 in Review
5 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2014, worth a combined $3.28M.
Buyers outnumbered sellers: 5 funds opened new BIOC positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Garrison Bradford & Associates, opening a new position worth an estimated $1.36M.
- 5 institutional investors held Biocept, Inc. (BIOC) as of Q1 2014, up from 0 in Q4 2013.
- Funds reported $3.28M of Biocept, Inc. stock for Q1 2014.
- 5 funds opened new Biocept, Inc. positions in Q1 2014 and 0 closed out, a net change of +5 holders.
- The largest Biocept, Inc. buyer in Q1 2014 was Garrison Bradford & Associates, an estimated $1.36M added.
Based on aggregated 13F filings for Q1 2014.